Elicio Therapeutics, Inc. (ELTX)
1.50
-0.09
(-5.66%)
USD |
NASDAQ |
Nov 19, 16:00
1.485
-0.02
(-1.00%)
Pre-Market: 20:00
Elicio Therapeutics EPS Diluted (Quarterly) : -0.3035 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.3035 |
| June 30, 2026 | -0.427 |
| March 31, 2026 | -0.6492 |
| December 31, 2025 | -0.4336 |
| September 30, 2025 | -0.604 |
| June 30, 2025 | -0.6576 |
| March 31, 2025 | -0.8655 |
| December 31, 2024 | -1.270 |
| September 30, 2024 | -1.387 |
| June 30, 2024 | -0.6406 |
| March 31, 2024 | -1.151 |
| December 31, 2023 | -0.9318 |
| September 30, 2023 | -1.272 |
| June 30, 2023 | -2.438 |
| Date | Value |
|---|---|
| March 31, 2023 | -8.277 |
| December 31, 2022 | -207.66 |
| September 30, 2022 | -226.70 |
| June 30, 2022 | -232.03 |
| March 31, 2022 | -4.753 |
| December 31, 2021 | 4.970 |
| September 30, 2021 | -5.265 |
| June 30, 2021 | -5.754 |
| March 31, 2021 | -15.65 |
| December 31, 2020 | -9.793 |
| September 30, 2020 | -5.993 |
| June 30, 2020 | -6.899 |
| March 31, 2020 | -4.484 |
| December 31, 2019 | -5.432 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | -0.0298 |
| Armata Pharmaceuticals, Inc. | -0.2351 |
| Voyager Therapeutics, Inc. | -0.3994 |
| Black Diamond Therapeutics, Inc. | -0.1743 |
| Invivyd, Inc. | -0.1038 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.979M |
| Total Expenses (Quarterly) | 7.979M |
| Enterprise Value | 25.55M |
| Earnings Yield | -120.9% |
| Normalized Earnings Yield | -128.95 |